PT1265914E - Polipéptidos relacionados com wnt-1 e ácidos nucleicos que codificam estes polipéptidos - Google Patents

Polipéptidos relacionados com wnt-1 e ácidos nucleicos que codificam estes polipéptidos Download PDF

Info

Publication number
PT1265914E
PT1265914E PT01920759T PT01920759T PT1265914E PT 1265914 E PT1265914 E PT 1265914E PT 01920759 T PT01920759 T PT 01920759T PT 01920759 T PT01920759 T PT 01920759T PT 1265914 E PT1265914 E PT 1265914E
Authority
PT
Portugal
Prior art keywords
wnt
same
nucleic acids
acids encoding
related polypeptides
Prior art date
Application number
PT01920759T
Other languages
English (en)
Inventor
Diane Pennica
Luca K Rastelli
Original Assignee
Geneprint Inc
Curagen Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Geneprint Inc, Curagen Corp filed Critical Geneprint Inc
Publication of PT1265914E publication Critical patent/PT1265914E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Seasonings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PT01920759T 2000-03-22 2001-03-22 Polipéptidos relacionados com wnt-1 e ácidos nucleicos que codificam estes polipéptidos PT1265914E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19125800P 2000-03-22 2000-03-22

Publications (1)

Publication Number Publication Date
PT1265914E true PT1265914E (pt) 2008-04-08

Family

ID=38885296

Family Applications (1)

Application Number Title Priority Date Filing Date
PT01920759T PT1265914E (pt) 2000-03-22 2001-03-22 Polipéptidos relacionados com wnt-1 e ácidos nucleicos que codificam estes polipéptidos

Country Status (11)

Country Link
US (3) US20020098540A1 (pt)
EP (1) EP1265914B1 (pt)
JP (1) JP2003527849A (pt)
AT (1) ATE382055T1 (pt)
AU (2) AU4778101A (pt)
CA (1) CA2404216A1 (pt)
DE (1) DE60132075T2 (pt)
DK (1) DK1265914T3 (pt)
ES (1) ES2298226T3 (pt)
PT (1) PT1265914E (pt)
WO (1) WO2001070775A2 (pt)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0114644D0 (en) * 2001-06-15 2001-08-08 Oxford Glycosciences Uk Ltd Protein
AU2003227504A1 (en) 2002-04-15 2003-10-27 Chugai Seiyaku Kabushiki Kaisha METHOD OF CONSTRUCTING scDb LIBRARY
WO2004065611A1 (ja) 2003-01-21 2004-08-05 Chugai Seiyaku Kabushiki Kaisha 抗体の軽鎖スクリーニング方法
US8597911B2 (en) 2003-06-11 2013-12-03 Chugai Seiyaku Kabushiki Kaisha Process for producing antibodies
EP1693386A4 (en) * 2003-11-04 2008-12-31 Chugai Pharmaceutical Co Ltd METHOD FOR THE PRODUCTION OF ANTIBODIES
US20050251054A1 (en) * 2004-05-10 2005-11-10 Medpond, Llc Method and apparatus for measurement of autonomic nervous system function
JP5057967B2 (ja) 2005-03-31 2012-10-24 中外製薬株式会社 ｓｃ（Ｆｖ）２構造異性体
EP3623473A1 (en) 2005-03-31 2020-03-18 Chugai Seiyaku Kabushiki Kaisha Process for production of polypeptide by regulation of assembly
CA2610987C (en) 2005-06-10 2013-09-10 Chugai Seiyaku Kabushiki Kaisha Stabilizer for protein preparation comprising meglumine and use thereof
CN101262885B (zh) 2005-06-10 2015-04-01 中外制药株式会社 含有sc(Fv)2的药物组合物
US9670269B2 (en) 2006-03-31 2017-06-06 Chugai Seiyaku Kabushiki Kaisha Methods of modifying antibodies for purification of bispecific antibodies
CN103695530B (zh) 2008-07-07 2016-05-25 牛津纳米孔技术有限公司 酶-孔构建体
WO2010004273A1 (en) 2008-07-07 2010-01-14 Oxford Nanopore Technologies Limited Base-detecting pore
GB0820927D0 (en) 2008-11-14 2008-12-24 Isis Innovation Method
EP2391655B1 (en) * 2009-01-30 2017-10-11 Oxford Nanopore Technologies Limited Hybridization linkers
AU2010209528B2 (en) 2009-01-30 2015-10-01 Oxford Nanopore Technologies Limited Adaptors for nucleic acid constructs in transmembrane sequencing
GB0905140D0 (en) 2009-03-25 2009-05-06 Isis Innovation Method
WO2012107778A2 (en) 2011-02-11 2012-08-16 Oxford Nanopore Technologies Limited Mutant pores
AU2012288629B2 (en) 2011-07-25 2017-02-02 Oxford Nanopore Technologies Limited Hairpin loop method for double strand polynucleotide sequencing using transmembrane pores
EP2836506B1 (en) 2012-04-10 2017-04-19 Oxford Nanopore Technologies Limited Mutant lysenin pores
US11155860B2 (en) 2012-07-19 2021-10-26 Oxford Nanopore Technologies Ltd. SSB method
GB201314695D0 (en) 2013-08-16 2013-10-02 Oxford Nanopore Tech Ltd Method
AU2014224432B2 (en) 2013-03-08 2019-10-24 Oxford Nanopore Technologies Limited Enzyme stalling method
GB201313477D0 (en) 2013-07-29 2013-09-11 Univ Leuven Kath Nanopore biosensors for detection of proteins and nucleic acids
DK3050896T3 (da) 2013-09-27 2021-07-19 Chugai Pharmaceutical Co Ltd Fremgangsmåde til fremstilling af en polypeptid-heteromultimer
GB201403096D0 (en) 2014-02-21 2014-04-09 Oxford Nanopore Tech Ltd Sample preparation method
EP3137490B1 (en) 2014-05-02 2021-01-27 Oxford Nanopore Technologies Limited Mutant pores
KR20170042794A (ko) 2014-09-01 2017-04-19 브이아이비 브이지더블유 돌연변이체 csgg 포어
US10266885B2 (en) 2014-10-07 2019-04-23 Oxford Nanopore Technologies Ltd. Mutant pores
GB201418159D0 (en) 2014-10-14 2014-11-26 Oxford Nanopore Tech Ltd Method
JP7219005B2 (ja) 2015-12-28 2023-02-07 中外製薬株式会社 Ｆｃ領域含有ポリペプチドの精製を効率化するための方法
GB201609220D0 (en) 2016-05-25 2016-07-06 Oxford Nanopore Tech Ltd Method
GB201807793D0 (en) 2018-05-14 2018-06-27 Oxford Nanopore Tech Ltd Method
CN114457052B (zh) * 2021-09-17 2024-02-27 厦门大学 一种抗肿瘤的多肽组合物及其应用

Also Published As

Publication number Publication date
DE60132075T2 (de) 2009-03-12
CA2404216A1 (en) 2001-09-27
US20050159373A1 (en) 2005-07-21
EP1265914A2 (en) 2002-12-18
US20080206252A1 (en) 2008-08-28
WO2001070775A3 (en) 2002-01-10
DK1265914T3 (da) 2008-03-10
WO2001070775A2 (en) 2001-09-27
EP1265914B1 (en) 2007-12-26
AU2001247781B2 (en) 2006-02-02
AU2001247781C1 (en) 2006-08-17
ES2298226T3 (es) 2008-05-16
AU4778101A (en) 2001-10-03
US20020098540A1 (en) 2002-07-25
ATE382055T1 (de) 2008-01-15
DE60132075D1 (de) 2008-02-07
JP2003527849A (ja) 2003-09-24

Similar Documents

Publication Publication Date Title
PT1265914E (pt) Polipéptidos relacionados com wnt-1 e ácidos nucleicos que codificam estes polipéptidos
NZ504548A (en) Polypeptides and nucleic acids encoding human chordin
HK1013847A1 (en) Gdf-1 and uog-1 proteins
ATE368053T1 (de) Antimikrobielle peptide
NZ335485A (en) Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereof
GB9823897D0 (en) Immunotherapeutic methods and molecules
EP0258411A4 (en) DNA ENCODING STREPTAVIDINE, STREPTAVIDINE PRODUCED FROM IT, FUSED POLYPEPTIDES WITH AMINO ACID SEQUENCES FROM STREPTAVIDINE AND USES.
WO2002016418A3 (en) An iap binding peptide or polypeptide and methods of using the same
WO2002101052A3 (en) Salutaridinol 7-o-acetyltransferase and derivatives thereof
DE69935599D1 (de) Modifizierte hcv peptid-impfstoffe
WO2003016342A3 (en) Tumor antigens for prevention and/or treatment of cancer
EP1117682A4 (en) NEW PEPTIDES
GB9416536D0 (en) Orphan receptor
WO2001098355A3 (en) Cgi-69 compositions and methods of use
WO2001070808A3 (en) Angiogenesis - associated proteins, and nucleic acids encoding the same
WO1999031229A3 (en) Peptides and nucleic acids derived from eisenia foetida and the use thereof
GB2357507A (en) Peptide fragments of cholera toxin B or enterotoxin B as vaccine adjuvants
EP0723016A3 (en) Leukocyte activation factor
WO2001049714A3 (en) Nope polypeptides, encoding nucleic acids and methods of use
DE69831584T2 (de) Polypeptide mit wasserkanalaktivität und dna sequenzen
ATE293163T1 (de) Cyclin e spezifische konstrukte und komplexe
WO1999031256A3 (en) Cathepsin dc proteins, dna encoding the proteins, and their use in human cancer prognosis
WO2002097036A3 (en) Compositions and methods for adipose abundant protein
WO2002096355A3 (en) Compositions and methods for adipose abundant protein
HUP0001462A2 (en) Human toll-like receptor proteins, related reagents and methods